166
Views
7
CrossRef citations to date
0
Altmetric
Research Article

Risk factors and predictors of levodopa-induced dyskinesia among multiethnic Malaysians with Parkinson's disease

, , , , &
Pages 187-191 | Received 22 Apr 2013, Accepted 07 Aug 2013, Published online: 27 Sep 2013

References

  • Barbeau A. Long-term side effects of levodopa. Lancet 1971;1:395.
  • Fabbrini G, Brotchie JM, Grandas F, Levodopa-induced dyskinesias. Mov Disord 2007;22(10):1379–89; quiz 1523.
  • Grandas F, Galiano ML, Tabernero C. Risk factors for levodopa-induced dyskinesias in Parkinson's disease. J Neurol 1999;246(12):1127–13.
  • Hauser RA, McDermott MP, Messing S. Factors associated with the development of motor fluctuations and dyskinesias in Parkinson disease. Arch Neurol 2006;63(12):1756–60.
  • Schrag A, Quinn N. Dyskinesias and motor fluctuations in Parkinson's disease. A community-based study. Brain 2000;123(Pt 11):2297–305.
  • Smith LA, Jackson MJ, Hansard MJ, Effect of pulsatile administration of levodopa on dyskinesia induction in drug-naïve MPTP-treated common marmosets: effect of dose, frequency of administration, and brain exposure. Mov Disord 2003;18(5):487–95.
  • Spencer SE, Wooten GF. Altered pharmacokinetics of L-dopa metabolism in rat striatum deprived of dopaminergic innervation. Neurology 1984;34(8):1105.
  • Kalinderi K, Fidani L, Katsarou Z, Bostantjopoulou S. Pharmacological treatment and the prospect of pharmacogenetics in Parkinson's disease. Int J Clin Pract 2011;65(12):1289–94.
  • Kumar N, Van Gerpen JA, Bower JH, Ahlskog JE. Levodopa-dyskinesia incidence by age of Parkinson's disease onset. Mov Disord 2005;20(3):342–4.
  • Ku S, Glass GA. Age of Parkinson's disease onset as a predictor for the development of dyskinesia. Mov Disord 2010;25(9):1177–82.
  • Nutt JG. Levodopa-induced dyskinesia: review, observations, and speculations. Neurology 1990;40(2):340–5.
  • Evans JR, Mason SL, Williams-Gray CH, The natural history of treated Parkinson's disease in an incident, community based cohort. J Neurol Neurosurg Psychiatry 2011;82(10):1112–8.
  • CM C. Parkinson's disease in Hong Kong –a study of 234 Chinese patients in a movement disorders clinic. J Hong Kong Med Assoc 1993;45:19–23.
  • Van Gerpen JA, Kumar N, Bower JH, Levodopa-associated dyskinesia risk among Parkinson disease patients in Olmsted County, Minnesota, 1976–1990. Arch Neurol 2006;63(2):205–9.
  • Chew NK, Goh KJ, Tan CT. Parkinson's disease in University Hospital Kuala Lumpur. Neurology Asia 1998;3:75–80.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.